Meeting
2023 ASCO Genitourinary Cancers Symposium
Effects of baseline C-reactive protein on prognosis in patients with metastatic non-clear cell renal cell carcinoma treated with systemic therapy.
Authors
Ryuichi Mizuno
Department of Urology, Keio University School of Medicine, Tokyo, Japan
Ryuichi Mizuno , Yota Yasumizu , Nobuyuki Tanaka , Kazuhiro Matsumoto , Mototsugu Oya
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 680)
DOI
10.1200/JCO.2023.41.6_suppl.680
Abstract #
680
Poster Bd #
H12
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Outcomes of systemic therapy in relapsed renal cell carcinoma (RCC) treated with adjuvant sunitinib (AS).
First Author: Guillermo de Velasco
Poster
2013 ASCO Annual Meeting
Prognostic value of early objective tumor response (EOTR) to first-line systemic therapy in metastatic colorectal cancer (mCRC): Individual patient data (IPD) meta-analysis of randomized trials from the ARCAD database.
First Author: Dirkje Willemien Sommeijer
Poster
2013 ASCO Annual Meeting
Advanced pulmonary carcinoid (APC): 20-year experience at Johns Hopkins (JH).
First Author: Patrick M. Forde
Poster
2024 ASCO Genitourinary Cancers Symposium
Neutrophil extracellular traps in relation to efficacy of systemic therapy for metastatic renal cell carcinoma.
First Author: Rui-Yang Xie